Business Wire

Internationally Acclaimed Public Health Researcher and Academic Leader Claire E. Sterk Named Emory University’s Next President

Del

The Emory University Board of Trustees announced today that Claire E. Sterk, provost and executive vice president for academic affairs at Emory, has been selected as the university’s 20th president. She was elected by a unanimous vote of the trustees during its meeting in Atlanta.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160603005802/en/

(Photo: Business Wire)

(Photo: Business Wire)

Sterk has been a member of the Emory community since 1995, when she was appointed to the faculty of the Rollins School of Public Health. During her tenure at Emory, she has served as the Charles Howard Candler Professor of Public Health, chair of the Department of Behavioral Sciences and Health Education, associate dean for research, and senior vice provost for academic affairs. She was named provost and executive vice president for academic affairs in 2013.

Sterk will assume the role on September 1. She will succeed James W. Wagner, who announced in September 2015 his intention to retire at the end of August 2016 after 13 years as president.

“Claire Sterk is a confident leader, an accomplished academic administrator, and a respected researcher,” says John Morgan, chair of the Emory University Board of Trustees and chair of the Presidential Selection Committee. “She has a sophisticated knowledge and understanding of Emory and is passionate about leveraging Emory’s considerable strengths and assets to enhance its global reputation and reach.”

Sterk was the unanimous choice presented to the Board of Trustees by a 15-member Presidential Selection Committee that has dedicated the past six months to an intensive national and international search.

“I am deeply grateful to the trustees for this extraordinary opportunity to serve as Emory’s president,” says Sterk. “Emory has earned its place among the world’s premier comprehensive research universities, and is well known for its undergraduate, graduate, and professional education; its leadership in research and scholarship across all disciplines; and an unsurpassed culture of innovation and collaboration. I look forward to engaging with all members of the Emory community to develop a shared vision for future success.”

Sterk is the first woman to serve as president of Emory. She is a native of the Netherlands, where she earned her Ph.D. in sociology from Erasmus University in Rotterdam and her doctorandus degree in medical anthropology from the University of Utrecht.

At Emory, Sterk has held faculty appointments in anthropology; sociology; and women, gender, and sexuality studies. Her primary research interests are addiction, mental health, and HIV/AIDS, with a focus on community-based interventions. She is a leading international figure in the fields of public health and anthropology and the author of three books and more than 100 articles and book chapters.

In addition to service on numerous editorial boards, Sterk has held several professional leadership positions, including president of the Alcohol, Drug, and Tobacco section of the American Sociological Association and a board member of the Society for Applied Anthropology.

Sterk’s husband and research partner, Kirk Elifson, serves on the faculty of the Rollins School of Public Health. Together, they have attracted more than $33 million in external research funding to Emory.

Emory University (http://www.emory.edu) is known for its demanding academics, outstanding undergraduate experience, highly ranked professional schools and state-of-the-art research facilities. Emory encompasses nine academic divisions as well as The Carter Center, the Yerkes National Primate Research Center, the Michael C. Carlos Museum, and Emory Healthcare, Georgia’s largest and most comprehensive health care system.

Contact information

Emory University
Nancy Seideman, 404-727-0640
Associate Vice President, Media Relations
nancy.seideman@emory.edu

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom